Abstract
Purpose
The purpose of this study was to compare inner retinal thickness and retinal nerve fiber layer (RNFL) thickness be-tween fellow eyes with unilateral branch retinal vein occlusion (BRVO) and normal control eyes.
Methods
Retrospective cross-sectional study including 59 patients diagnosed with unilateral BRVO and 51 control subjects. Using spectral domain optical coherence tomography, we investigated the average, 4 quadrant, and 12 clock-hour RNFL thick-nesses and the average, minimum, superior, superonasal, superotemporal, inferior, inferonasal, and inferotemporal thicknesses of the ganglion cell-inner plexiform layer (GCIPL) layer.
Results
Patients with unilateral BRVO had a higher incidence of hypertension. In the fellow eyes of the unilateral BRVO pa-tients, 7 and 11 o’clock RNFL thicknesses were significantly thinner than for the control eyes. There was no significant difference in the GCIPL thickness between the two groups
Conclusions
The RNFL thickness of the fellow eyes of the unilateral BRVO patients showed significant decreases in the 7 and 11 o’clock sectors ( p=0.005, 0.017, respectively), whereas there was no significant difference in the GCIPL thickness between the two groups. In the RNFL thickness analysis, the 7 and 11 o’clock sectors were found to be dominant locations of decreased RNFL thickness for the open angle glaucoma. Further, glaucomatous change should be carefully monitored in the fellow eyes of unilateral BRVO patients.
References
1. Luntz MH, Schenker HI. Retinal vascular accidents in glaucoma and ocular hypertension. Surv Ophthalmol. 1980; 25:163–7.
2. Krakau CE. Disk hemorrhages and retinal vein occlusions in glaucoma. Surv Ophthalmol. 1994; 38(Suppl):S18–21.
3. Sonnsjö B, Krakau CE. Arguments for a vascular glaucoma etiology. Acta Ophthalmol (Copenh). 1993; 71:433–44.
4. Yoo YC, Park KH. Disc hemorrhages in patients with both normal tension glaucoma and branch retinal vein occlusion in different eyes. Korean J Ophthalmol. 2007; 21:222–7.
5. Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992; 99:509–14.
6. Risk factors for branch retinal vein occlusion. The Eye Disease Case-control Study Group. Am J Ophthalmol. 1993; 116:286–96.
7. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1996; 114:545–54.
8. Stewart RM, Clearkin LG. Insulin resistance and autoregulatory dysfunction in glaucoma and retinal vein occlusion. Am J Ophthalmol. 2008; 145:394–6.
9. Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk fac-tor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004; 21:609–14.
10. Ellis JD, Evans JM, Ruta DA. . Glaucoma incidence in an un-selected cohort of diabetic patients: is diabetes mellitus a risk fac-tor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring Unit. Br J Ophthalmol. 2000; 84:1218–24.
11. Pasquale LR, Kang JH, Manson JE. . Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006; 113:1081–6.
12. Gordon MO, Beiser JA, Brandt JD. . The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:714–20.
13. Hulsman CA, Vingerling JR, Hofman A. . Blood pressure, ar-terial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol. 2007; 125:805–12.
14. Kim MJ, Woo SJ, Park KH, Kim TW. Retinal nerve fiber layer thickness is decreased in the fellow eyes of patients with unilateral retinal vein occlusion. Ophthalmology. 2011; 118:706–10.
15. Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981; 99:137–43.
16. Jonas JB, Gusek GC, Naumann GO. Optic disc morphometry in chronic primary open-angle glaucoma. I. Morphometric intra-papillary characteristics. Graefes Arch Clin Exp Ophthalmol. 1988; 226:522–30.
17. Janáky M, Grósz A, Tóth E. . Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. Doc Ophthalmol. 2007; 114:45–51.
18. Tinjust D, Kergoat H, Lovasik JV. Neuroretinal function during mild systemic hypoxia. Aviat Space Environ Med. 2002; 73:1189–94.
19. Chhablani J, Rao HB, Begum VU. . Retinal ganglion cells thin-ning in eyes with nonproliferative idiopathic macular telangiectasia type 2A. Invest Ophthalmol Vis Sci. 2015; 56:1416–22.
20. Jeoung JW, Choi YJ, Park KH, Kim DM. Macular ganglion cell imaging study: glaucoma diagnostic accuracy of spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54:4422–9.
Table 1.
RVO Fellow eye (n = 59) | Control (n = 48) | p-value | |
---|---|---|---|
Age (years) | 63.4 ± 9.6 | 62.9 ± 9.8 | 0.763* |
Gender (male/female) | 18/41 | 15/33 | 0.934† |
Hypertension (n) | 30 | 13 | 0.013† |
Diabetes mellitus (n) | 12 | 3 | 0.037† |
Refraction (D) | -0.12 ± 1.51 | 0.16 ± 1.09 | 0.204* |
Mean IOP (mmHg) | 14.98 ± 3.17 | 15.73 ± 3.69 | 0.234* |
Table 2.
RNFL thickness (μ m) | RVO fellow eye (μ m) (n = 59) | Control (μ m) (n = 48) | p-value* |
---|---|---|---|
Average RNFL thickness | 87.87 ± 11.09 | 89.00 ± 7.46 | 0.705 |
Superior quadrant | 107.29 ± 17.05 | 109.28 ± 15.06 | 0.286 |
Nasal quadrant | 63.85 ± 8.98 | 66.34 ± 7.06 | 0.104 |
Inferior quadrant | 111.91 ± 22.05 | 114.69 ± 12.38 | 0.551 |
Temporal quadrant | 65.97 ± 10.54 | 65.51 ± 9.70 | 0.821 |
1-o’clock | 101.04 ± 21.35 | 100.45 ± 22.18 | 0.390 |
2-o’clock | 75.51 ± 14.94 | 77.52 ± 13.23 | 0.704 |
3-o’clock | 55.73 ± 7.87 | 55.62 ± 7.98 | 0.764 |
4-o’clock | 60.36 ± 10.00 | 61.76 ± 8.08 | 0.688 |
5-o’clock | 105.43 ± 26.40 | 105.75 ± 24.28 | 0.911 |
6-o’clock | 121.73 ± 22.54 | 123.39 ± 28.43 | 0.871 |
7-o’clock | 118.04 ± 22.16 | 134.87 ± 18.40 | 0.005 |
8-o’clock | 67.28 ± 14.34 | 66.91 ± 13.48 | 0.684 |
9-o’clock | 54.93 ± 8.65 | 54.62 ± 7.80 | 0.391 |
10-o’clock | 75.32 ± 13.35 | 76.19 ± 14.94 | 0.704 |
11-o’clock | 112.59 ± 21.83 | 124.24 ± 17.42 | 0.017 |
12-o’clock | 118.49 ± 19.24 | 115.76 ± 20.51 | 0.063 |
Table 3.
GCIPL thickness (μ m) | RVO Fellow eye (μ m) (n = 59) | Control (μ m) (n = 48) | p-value* |
---|---|---|---|
Average | 79.05 ± 11.22 | 80.08 ± 6.64 | 0.640 |
Minimum | 73.52 ± 13.97 | 76.77 ± 8.91 | 0.223 |
Superornasal | 81.46 ± 12.33 | 81.33 ± 7.36 | 0.995 |
Superior | 79.32 ± 12.07 | 80.23 ± 6.23 | 0.375 |
Superotemporal | 78.43 ± 11.63 | 79.33 ± 5.99 | 0.223 |
Inferotemporal | 79.51 ± 10.46 | 80.54 ± 7.47 | 0.600 |
Inferior | 76.68 ± 12.64 | 79.29 ± 7.06 | 0.395 |
Inferonasal | 78.13 ± 13.04 | 79.37 ± 8.94 | 0.986 |